Evaluation of the Safety and Efficacy of Concentrated Growth Factors for Hair Growth Promotion in Androgenetic Alopecia Patients: A Retrospective Single-Center, Single-Arm Study

    August 2024 in “ Journal of Cosmetic Dermatology
    Saisai Cao, Mengyi Zhu, Ye Bi
    Image of study
    TLDR CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.
    This retrospective single-center, single-arm study evaluated the safety and efficacy of concentrated growth factor (CGF) injections for promoting hair growth in androgenetic alopecia (AGA) patients. Conducted from October 2021 to April 2023, the study involved administering 3 CGF injections every 3-4 weeks to AGA patients, with evaluations at 3 and 6 months post-treatment. Results showed significant improvements in hair density and growth ratio, as well as in Global Aesthetic Improvement Scale (GAIS) scores, sustained for 6 months. No severe adverse events were reported, suggesting CGF injections may effectively increase terminal hair density and overall hair density in AGA patients.
    Discuss this study in the Community →

    Cited in this study

    26 / 26 results

    Related

    6 / 6 results